Get the Stockscreener App
2.20
3.29%
0.07
Kalaris Therapeutics Inc Stock (KLRS) Forecast
The Kalaris Therapeutics Inc (KLRS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.0156, representing a -53.83% decrease from the current price of $2.20. The highest analyst price target is $1.0635, and the lowest is $0.9678.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month KLRS Price Target
Average 3.188
(+44.91% Upside)
Is Kalaris Therapeutics Inc (KLRS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 21.71 | Buy |
| STOCH(9,6) | 8.2894 | Buy |
| STOCHRSI(14) | 35.51 | Neutral |
| MACD(12,26) | -0.3457 | Sell |
| ADX(14) | 51.46 | Sell |
| William %R | -88.51 | Buy |
| CCI(14) | -75.89 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.443
Sell
|
2.4199
Sell
|
| MA20 |
2.7355
Sell
|
2.6898
Sell
|
| MA50 |
3.4008
Sell
|
3.2411
Sell
|
| MA100 |
3.8831
Sell
|
3.9245
Sell
|
| MA200 |
5.7752
Sell
|
4.4542
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, KLRS could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on KLRS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 21.71 indicates that KLRS is oversold. This indicates that KLRS price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 8.2894 indicates that KLRS is oversold. This indicates that KLRS price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 35.51 indicates that KLRS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 51.46 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -75.89 indicates that KLRS is still oversold but not to an extreme extent.
Long-term KLRS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Kalaris Therapeutics Inc financial reports and earnings history, Kalaris Therapeutics Inc (KLRS) stock could reach $1.9465 by 2030, $46.29 by 2040 and $28.88 by 2050. See the projected annual prices until 2050 of the Kalaris Therapeutics Inc stock below:
- Kalaris Therapeutics Inc (KLRS) is expected to reach an average price of $13.22 in 2035, with a high prediction of $15.09 and a low estimate of $13.62. This indicates an $501.13% rise from the last recorded price of $2.20.
- Kalaris Therapeutics Inc (KLRS) stock is projected to chart a bullish course in 2040, with an average price target of $45.02, representing an $1,947% surge from its current level. The forecast ranges from a conservative $45.09 to a sky-high $46.29.
- Our analysts predict Kalaris Therapeutics Inc (KLRS) to jump 3,682% by 2045, soaring from $83.40 to an average price of $83.21, potentially reaching $85.06. While $83.40 is the low estimate, the potential upside is significant.
- Kalaris Therapeutics Inc (KLRS) stock is expected to climb by 2050, reaching an average of $25.87, a $1,076% jump from its current level. However, a wide range of estimates exists, with high and low targets of $28.88 and $25.98, respectively, highlighting the market's uncertainty.
Kalaris Therapeutics Inc Stock (KLRS) Year by Year Forecast
Kalaris Therapeutics Inc Stock (KLRS) Price Forecast for 2026
The predicted value for Kalaris Therapeutics Inc (KLRS) in 2026 is set at an average of $5.8045. Estimates vary from a peak of $11.21 to a trough of $0.3939, indicating an +163.84% surge from the present price of $2.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $1.7135 | $0.9678 | $1.0635 | -22.12% |
| December, 2026 | $4.6291 | $2.0774 | $3.9691 | +110.41% |
Kalaris Therapeutics Inc Stock (KLRS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Kalaris Therapeutics Inc (KLRS) is $3.274, with a high forecast of $6.5299 and a low forecast of $0.0181. This indicates an +48.82% increase from the last price of $2.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.1647 | $4.9808 | $4.8619 | +134.76% |
| February, 2027 | $5.0004 | $4.9565 | $4.9527 | +127.29% |
| March, 2027 | $4.4299 | $4.5599 | $4.7723 | +101.36% |
| April, 2027 | $2.7356 | $4.3156 | $4.2678 | +24.34% |
| May, 2027 | $0.6551 | $0.9042 | $1.7634 | -70.22% |
| June, 2027 | $1.3608 | $0.579 | $2.5221 | -38.15% |
| July, 2027 | $1.1836 | $0.5964 | $1.3136 | -46.20% |
| August, 2027 | $3.809 | $0.0181 | $6.358 | +73.14% |
| September, 2027 | $4.5984 | $2.6973 | $5.0249 | +109.02% |
| October, 2027 | $3.8128 | $3.3367 | $5.4837 | +73.31% |
| November, 2027 | $2.1132 | $2.0932 | $6.5299 | -3.94% |
| December, 2027 | $2.1476 | $0.8593 | $2.9876 | -2.38% |
Kalaris Therapeutics Inc Stock (KLRS) Price Forecast for 2028
In 2028, Kalaris Therapeutics Inc (KLRS) is projected to reach an average price of $6.533, with a high projection of $12.82 and a low estimate of $0.2472. This indicates an +196.96% rise from the last price of $2.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.308 | $1.188 | $2.6798 | -40.54% |
| February, 2028 | $0.9724 | $0.8241 | $2.0563 | -55.80% |
| March, 2028 | $0.9067 | $0.6251 | $1.4846 | -58.78% |
| April, 2028 | $0.8711 | $0.6611 | $3.315 | -60.40% |
| May, 2028 | $1.5515 | $0.2472 | $1.8315 | -29.48% |
| June, 2028 | $1.0259 | $0.8659 | $1.8087 | -53.37% |
| July, 2028 | $0.3364 | $0.3164 | $1.202 | -84.71% |
| August, 2028 | $10.20 | $7.64 | $8.6835 | +363.79% |
| September, 2028 | $10.40 | $10.41 | $9.4769 | +372.94% |
| October, 2028 | $13.01 | $10.99 | $12.82 | +491.54% |
| November, 2028 | $12.69 | $12.86 | $12.61 | +476.60% |
| December, 2028 | $12.31 | $12.37 | $12.43 | +459.38% |
Kalaris Therapeutics Inc Stock (KLRS) Price Forecast for 2029
The 2029 price forecast for Kalaris Therapeutics Inc Stock (KLRS) is $5.9711 on average, with a high prediction of $11.57 and a low estimate of $0.3679. This represents an +171.41% increase from the previous price of $2.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $11.48 | $11.63 | $11.57 | +421.61% |
| February, 2029 | $9.4368 | $9.5168 | $11.14 | +328.94% |
| March, 2029 | $6.0781 | $6.9381 | $7.8746 | +176.28% |
| April, 2029 | $7.2072 | $7.4472 | $7.1915 | +227.60% |
| May, 2029 | $5.4635 | $5.8406 | $6.3155 | +148.34% |
| June, 2029 | $2.2997 | $1.7719 | $2.3263 | +4.53% |
| July, 2029 | $1.0988 | $1.091 | $2.0577 | -50.05% |
| August, 2029 | $1.0899 | $0.4399 | $1.8449 | -50.46% |
| September, 2029 | $3.3714 | $0.3679 | $1.9114 | +53.25% |
| October, 2029 | $1.8905 | $2.0005 | $2.4317 | -14.07% |
| November, 2029 | $2.4918 | $2.2561 | $2.0045 | +13.26% |
| December, 2029 | $1.9109 | $2.0374 | $2.1031 | -13.14% |
Kalaris Therapeutics Inc Stock (KLRS) Price Forecast for 2030
Kalaris Therapeutics Inc Stock (KLRS) is expected to reach an average price of $10.80 in 2030, with a high forecast of $20.78 and a low forecast of $0.8325. This signifies an +391.10% surge from the last price of $2.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.5822 | $1.6922 | $1.9465 | -28.08% |
| February, 2030 | $1.3434 | $1.63 | $1.7256 | -38.93% |
| March, 2030 | $0.7647 | $0.9747 | $1.0813 | -65.24% |
| April, 2030 | $1.1538 | $0.8325 | $1.0738 | -47.55% |
| May, 2030 | $15.61 | $1.3816 | $14.11 | +609.55% |
| June, 2030 | $18.47 | $17.98 | $17.37 | +739.41% |
| July, 2030 | $21.08 | $18.75 | $18.65 | +857.98% |
| August, 2030 | $20.34 | $20.74 | $20.78 | +824.66% |
| September, 2030 | $20.00 | $20.00 | $20.34 | +809.14% |
| October, 2030 | $18.91 | $18.97 | $19.62 | +759.46% |
| November, 2030 | $18.16 | $18.31 | $18.61 | +725.68% |
| December, 2030 | $13.92 | $15.21 | $16.31 | +532.89% |
1.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):